Welcome to LookChem.com Sign In|Join Free
  • or
2-Amino-6-bromoquinazolin-4-ol is a quinazolin-4-ol derivative, a class of chemical compounds with potential pharmacological activities. It features a bromine atom at the 6th position and an amino group at the 2nd position, making it a versatile and functionalized quinazoline derivative. 2-aMino-6-broMoquinazolin-4-ol serves as a building block in medicinal chemistry research for the synthesis of biologically active compounds targeting various diseases, such as cancer and neurological disorders. Its structure, including the presence of an amino group and a hydroxyl group, allows for further chemical modifications to enhance its biological activities and improve its pharmacokinetic properties.

130148-53-7

Post Buying Request

130148-53-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

130148-53-7 Usage

Uses

Used in Medicinal Chemistry Research:
2-Amino-6-bromoquinazolin-4-ol is used as a building block for the synthesis of various biologically active compounds due to its functionalized quinazoline structure. It contributes to the development of new drugs targeting a wide range of diseases, including cancer and neurological disorders.
Used in Drug Development:
In the pharmaceutical industry, 2-Amino-6-bromoquinazolin-4-ol is utilized as an important scaffold for the creation of new drugs. Its unique structure allows for chemical modifications to optimize its biological activities and pharmacokinetic properties, making it a promising candidate for the treatment of various diseases.
Used in Cancer Research:
2-Amino-6-bromoquinazolin-4-ol is employed as a potential anticancer agent in cancer research. Its structure and functional groups enable it to target specific cellular pathways and mechanisms involved in cancer development and progression, offering a promising avenue for the discovery of novel therapeutic agents.
Used in Neurological Disorder Research:
In the field of neurological disorders, 2-Amino-6-bromoquinazolin-4-ol is used as a compound of interest for the development of treatments targeting various neurological conditions. Its potential to modulate specific biological activities makes it a valuable tool in the search for effective therapies.
Overall, 2-Amino-6-bromoquinazolin-4-ol is a versatile and valuable compound in the fields of medicinal chemistry, drug development, cancer research, and neurological disorder research, with its potential applications extending to the creation of novel therapeutic agents and the enhancement of existing treatments.

Check Digit Verification of cas no

The CAS Registry Mumber 130148-53-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,0,1,4 and 8 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 130148-53:
(8*1)+(7*3)+(6*0)+(5*1)+(4*4)+(3*8)+(2*5)+(1*3)=87
87 % 10 = 7
So 130148-53-7 is a valid CAS Registry Number.

130148-53-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Amino-6-bromoquinazolin-4-ol

1.2 Other means of identification

Product number -
Other names 2-amino-6-bromo-1H-quinazolin-4-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:130148-53-7 SDS

130148-53-7Downstream Products

130148-53-7Relevant academic research and scientific papers

Structure-Based Design of Highly Potent Toll-like Receptor 7/8 Dual Agonists for Cancer Immunotherapy

Wang, Zhisong,Gao, Yan,He, Lei,Sun, Shuhao,Xia, Tingting,Hu, Lu,Yao, Licheng,Wang, Liangliang,Li, Dan,Shi, Hui,Liao, Xuebin

supporting information, p. 7507 - 7532 (2021/06/28)

Activation of the toll-like receptors 7 and 8 has emerged as a promising strategy for cancer immunotherapy. Herein, we report the design and synthesis of a series of pyrido[3,2-d]pyrimidine-based toll-like receptor 7/8 dual agonists that exhibited potent and near-equivalent agonistic activities toward TLR7 and TLR8. In vitro, compounds 24e and 25a significantly induced the secretion of IFN-α, IFN-γ, TNF-α, IL-1β, IL-12p40, and IP-10 in human peripheral blood mononuclear cell assays. In vivo, compounds 24e, 24m, and 25a significantly suppressed tumor growth in CT26 tumor-bearing mice by remodeling the tumor microenvironment. Additionally, compounds 24e, 24m, and 25a markedly improved the antitumor activity of PD-1/PD-L1 blockade. In particular, compound 24e combined with the anti-PD-L1 antibody led to complete tumor regression. These results demonstrated that TLR7/8 agonists (24e, 24m, and 25a) held great potential as single agents or in combination with PD-1/PD-L1 blockade for cancer immunotherapy.

Synthesis of 2-Aminoquinazolinones via Carbonylative Coupling of ortho-Iodoanilines and Cyanamide

?kerbladh, Linda,Odell, Luke R.

, p. 2966 - 2973 (2016/04/26)

Herein, we describe a convenient and efficient synthesis of 2-aminoquinazolin-4(3H)-ones and N1-substituted 2-aminoquinazolin-4(1H)-ones by a domino carbonylation/cyclization process. The reaction proceeds via carbonylative coupling of readily available ortho-iodoanilines with cyanamide followed by in situ ring closure of an N-cyanobenzamide intermediate. The products were easily isolated by precipitation in moderate to excellent yields for a wide range of substrates, making this a highly attractive method for the synthesis of 2-aminoquinazolinones.

Regioselective Synthesis of Imidazoquinazoline Quinone Nucleosides and Quinazoline Amino Nucleosides. Studies of Their Xanthine Oxidase and Purine Nucleoside Phosphorylase Substrate Activity

O'Hara Dempcy, Robert,Skibo, Edward B.

, p. 776 - 785 (2007/10/02)

The regioselective synthesis of 3-ribofuranosylimidazoquinazoline-4,8,9(3H,7H)-trione (1) (benzoquinone-stretched-out inosine) and 8-(ribofuranosylamino)quinazolin-4(3H)-one (2) was carried out in conjunction with the design of reductive alkylating nucleosides and new purine nucleoside mimics, respectively.The preparation of 1 was carried out by regioselective ribosylation of 4-nitroimidazoquinazolin-8(3H,7H)-one (3) followed by nitro group reduction, Fremy oxidation, and deacetylation.Regiocontrol of ribosylation has steric origins: the 4-nitro group of 3 directs silylation to the N(1) position, which results in ribosylation exclusively at the N(3) position under Vorbrueggen reaction conditions.Regiocontrol during the preparation of 2 was possible by generating a stabilized ribofuranosyl carbocation, which selectively reacts with the amine group of the base.Nucleoside 1 is a purine-like quinone by virtue of its oxidation by xanthine oxidase.The potential inosine mimic 2 does not undergo phosphorolysis by purine nucleoside phosphorylase (PNPase), but the base form (8-aminoquinazolin-4(3H)-one) does bind to the PNPase active site as tightly as hypoxanthine.Factors which contribute to this binding behavior are discussed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 130148-53-7